摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

16-Amino-7-oxo-2,5,8-triazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(9),3,5,10,12,14-hexaene-4-carboxylic acid

中文名称
——
中文别名
——
英文名称
16-Amino-7-oxo-2,5,8-triazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(9),3,5,10,12,14-hexaene-4-carboxylic acid
英文别名
——
16-Amino-7-oxo-2,5,8-triazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(9),3,5,10,12,14-hexaene-4-carboxylic acid化学式
CAS
——
化学式
C14H10N4O3
mdl
——
分子量
282.258
InChiKey
SSYFOUWTJLNWJL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.6
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    110
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Synthesis of anticonvulsive AMPA antagonists
    摘要:
    The overstimulation of excitatory amino acid receptors such as the glutamate AMPA receptor has been implicated in the physiopathogenesis of egilepsy as well as ill acute and chronic neurodegenerative disorders. An original series of readily water soluble 4-oxo-10-substituted-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives was synthesized. The most potent derivative 6a exhibited nanomolar binding affinity (IC50=35nM) and antagonist activity (IC50-6nM) at ionotropic AMPA receptor. This compound also demonstrated potent anticonvulsant properties in MES in mice and rats with long durations of action with ED50 values in the 1-3 mg/kg dose range following ip and iv administration. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00180-9
点击查看最新优质反应信息

文献信息

  • Synthesis of anticonvulsive AMPA antagonists
    作者:Jean-Marie Stutzmann、Georg Andrees Bohme、Alain Boireau、Dominique Damour、Marc Williams Debono、Arielle Genevois-Borella、Patrick Jimonet、Jeremy Pratt、John C.R Randle、Yves Ribeill、Marc Vuilhorgne、Serge Mignani
    DOI:10.1016/s0960-894x(01)00180-9
    日期:2001.5
    The overstimulation of excitatory amino acid receptors such as the glutamate AMPA receptor has been implicated in the physiopathogenesis of egilepsy as well as ill acute and chronic neurodegenerative disorders. An original series of readily water soluble 4-oxo-10-substituted-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives was synthesized. The most potent derivative 6a exhibited nanomolar binding affinity (IC50=35nM) and antagonist activity (IC50-6nM) at ionotropic AMPA receptor. This compound also demonstrated potent anticonvulsant properties in MES in mice and rats with long durations of action with ED50 values in the 1-3 mg/kg dose range following ip and iv administration. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

咪唑并[1,2-a]噻吩并[3,2-E]吡嗪-5(4H)-酮 8-羟基咪唑并[1,2-a]吡嗪 5H,10H-二咪唑并[1,2-a:1,2-d]吡嗪-5,10-二酮 5H,10H-二咪唑并[1,2-a:1',5'-d]吡嗪-5,10-二酮 5,6,7,8-四氢-4H-环戊二烯并[E]咪唑并[1,2-a]吡嗪-4-酮 8-(3-benzylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-(3-butylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-(3-isopropylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 2-nitroimidazo[1,2-a]pyrazin-8(7H)-one 8-(4-methylpentanoyl)amino-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 3-(10-methyl-4,5-dihydro-4-oxo-10H-imidazo-[1,2-a]indeno[1,2-e]pyrazin-10-yl)propionitrile 10-[(1-methylimidazol-5-yl)methylene]-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one hydrochloride 8-(3-tert-butylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-(3-methylthioureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 10-formamido-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one 10-amino-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one hydrochloride 8-hydroxy-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-Methoxy-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-[3-morpholinoureido]-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazine-4-one hydrate 7-chloro-10-methylamino-5H,10H-imidazo-[1,2-a]indeno[1,2-e]pyrazin-4-one hydrochloride 7-chloro-10-formamido-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-acetamido-7-chloro-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-(2-pyridylmethyl)-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 10-(4-imidazolylmethyl)-5H,10H-imidazo[1,2-a]-indeno[1,2-e]pyrazin-4-one 10-(pyridin-2-ylmethylene)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-(4-imidazolylmethylene)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 5H,10H-8-aminoimidazo[1,2-a]indeno[1,2-e]pyrazine-4-one monohydrochloride 10-(carboxymethylene)-8-(3-methylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 8-amino-10-(carboxymethylene)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one dihydrochloride 8-ureido-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one [4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-8-yl]acetic acid 10-(2-methyl-1-propenyl)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one RPR 119990 3-(9-carboxymethyl-4-oxo-5,10-dihydroimidazo[1,2-a]indeno[1,2-e]pyrazin-2-yl]propionic acid 10-[4-(imidazol-1-yl)butyl]-10-methyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 12-Methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,9,11-tetraen-8-one 3-bromo-7-methyl-imidazo[1,2-a]pyrazin-8-one 5-chloro-7-methyl-8-oxo-6-phenyl-7,8-dihydroimidazo[1,2-a]-pyrazine-3-carbaldehyde ethyl 9-(diethoxyphosphorylmethyl)-4-oxo-5,10-dihydroimidazo[1,2-a]indeno[1,2-e]pyrazine-2-carboxylate ethyl 8-fluoro-4-oxo-4,5-dihydro-10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-2-carboxylate 2-methyl-7H-imidazo[1,2-a]pyrazin-8-one 2-Methyl-7-[(1-phenylcyclopropyl)methyl]imidazo[1,2-a]pyrazin-8-one 3-bromo-2-methyl-7-(1-phenyl-cyclopropylmethyl)-7H-imidazo[1,2-a]pyrazin-8-one 5-chloro-7-(4-methoxybenzyl)-8-oxo-7,8-dihydroimidazo[1,2-a]-pyrazine-3-carbaldehyde 10-hydroxymethylene-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-(carboxymethylene)-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 10-(carboxymethyl)-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one 8-oxo-7,8-dihydroimidazo[1,2-a]pyrazine hydrochloride 10-amino-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one 10-(4-phenylbutyramido)-5H,10H-imidazo[1,2-a]-indeno[1,2-e]pyrazin-4-one